Peer-reviewed publication in “The Oncologist” is now available onlineInvestigational same-day dosing of Rolvedon demonstrated a clinical response and adverse event profile similar to next-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback